Computational screening of potential anti-inflammatory leads from Jeevaneeya Rasayana plants targeting COX-2 and 5-LOX by molecular docking and dynamic simulation approaches

被引:2
|
作者
Hemavathi, Kadabagere Narayanaswamy [1 ]
Skariyachan, Sinosh [2 ]
Raju, Rajesh [3 ]
Prasad, Thottethodi Subramanya Keshava [1 ]
Abhinand, Chandran S. [1 ]
机构
[1] Yenepoya Deemed Univ, Ctr Syst Biol & Mol Med, Yenepoya Res Ctr, Mangalore, India
[2] St Pius X Coll, Dept Microbiol, Kasaragod, India
[3] Yenepoya Deemed Univ, Ctr Integrat Om Data Sci, Mangalore, India
关键词
Inflammation; COX-2; 5-LOX; Jeevaneeya rasayana; Phytocompounds; Molecular docking; Molecular dynamics; DRUG DISCOVERY; INFLAMMATION; INHIBITORS; ANTIOXIDANT; MECHANISMS; PREDICTION; KNOWLEDGE;
D O I
10.1016/j.compbiomed.2024.108164
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Inflammation plays a pivotal role in various pathological processes, ranging from routine injuries and infections to cancer. Cyclooxygenase-2 (COX -2) and 5-lipoxygenase (5 -LOX) are two major enzymes involved in the formation of lipid mediators of inflammation, such as prostaglandins and leukotrienes, through the arachidonic acid pathway. Despite the frequent use of nonsteroidal anti-inflammatory drugs for managing inflammatory disorders by inhibiting these enzymes, there is a wide spectrum of adverse effects linked to their usage. Jeevaneeya Rasayana (JR), a polyherbal formulation traditionally used in India, is renowned for its anti-inflammatory properties. The present study aimed to identify the potential phytocompounds in JR plants against COX -2 and 5 -LOX, utilizing molecular docking and dynamic simulations. Among the 429 identified phytocompounds retrieved from publicly available data sources, Terrestribisamide and 1-(9Z-octadecenoyl)-sn-glycero-3-phos- phoethanolamine have shown potential binding affinity and favorable interactions with COX -2 and 5 -LOX arachidonic acid binding sites. The physicochemical properties and ADMET profiles of these compounds determined their drug -likeness and pharmacokinetics features. Additional validation using molecular dynamics simulations, SASA, Rg, and MM-PBSA binding energy calculations affirmed the stability of the complex formed between those compounds with target proteins. Together, the study identified the effectual binding potential of those bioactive compounds against COX -2 and 5 -LOX, providing a viable approach for the development of effective anti-inflammatory medications.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Synthesis of diarylidenecyclohexanone derivatives as potential anti-inflammatory leads against COX-2/mPGES1 and 5-LOX
    Kar, Swayamsiddha
    Ramamoorthy, Gayathri
    Sinha, Shweta
    Ramanan, Meera
    Pola, Jeevan Kumar
    Golakoti, Nageswara Rao
    Nanubolu, Jagadeesh Babu
    Sahoo, Suraj Kumar
    Dandamudi, Rajesh Babu
    Doble, Mukesh
    NEW JOURNAL OF CHEMISTRY, 2019, 43 (23) : 9012 - 9020
  • [2] COX-2/5-LOX dual acting anti-inflammatory drugs in cancer chemotherapy
    Goossens, Laurence
    Pommery, Nicole
    Henichart, Jean Pierre
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (03) : 283 - 296
  • [3] Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives
    Chaaban, Ibrahim
    Rizk, Ola H.
    Ibrahim, Tamer M.
    Henen, Shery S.
    El-Khawass, Sayeda M.
    Bayad, Aida E.
    El-Ashmawy, Ibrahim M.
    Nematalla, Hisham A.
    BIOORGANIC CHEMISTRY, 2018, 78 : 220 - 235
  • [4] Molecular docking investigation of anti-inflammatory herbal compounds as potentia LOX-5 and COX-2 inhibitors
    Vyshnevska, Liliia
    Severina, Hanna, I
    Prokopenko, Yuliya
    Shmalko, Alexander
    PHARMACIA, 2022, 69 (03) : 733 - 744
  • [5] The anti-inflammatory pharmacology of Pycnogenol® in humans involves COX-2 and 5-LOX mRNA expression in leukocytes
    Canali, Raffaella
    Comitato, Raffaella
    Schonlau, Frank
    Virgili, Fabio
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (10) : 1145 - 1149
  • [6] Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in -vitro and in -vivo biological evaluation for anti-inflammatory activity
    Jacob, Jaismy P.
    Manju, S. L.
    BIOORGANIC CHEMISTRY, 2020, 100
  • [7] Indole based peptidomimetics as anti-inflammatory and anti-hyperalgesic agents: Dual inhibition of 5-LOX and COX-2 enzymes
    Singh, Palwinder
    Prasher, Parteek
    Dhillon, Parvirti
    Bhatti, Rajbir
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 97 : 104 - 123
  • [8] Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach
    Jacob, Jaismy P.
    Manju, S. L.
    Ethiraj, K. R.
    Elias, Geetha
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 121 : 356 - 381
  • [9] Synthesis of Pyrrolidine-2,5-dione Based Anti-inflammatory Drug: In Vitro COX-2, 5-LOX Inhibition and In Vivo Anti-inflammatory Studies
    Jan, Muhammad S.
    Shahid, Muhammad
    Ahmad, Sajjad
    Hussain, Fida
    Ahmad, Ashfaq
    Mahmood, Fawad
    Rashid, Umer
    Ullah, Farhat
    Khan, Nadir Z.
    Aasim, Muhammad
    Ayaz, Muhammad
    Khan, Jahangir
    Abdullah
    Rahim, Haron
    Sadiq, Abdul
    LATIN AMERICAN JOURNAL OF PHARMACY, 2019, 38 (11): : 2287 - 2294
  • [10] Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies
    Abdelgawad, Mohamed A.
    Labib, Madlen B.
    Ali, Waleed A. M.
    Kamel, Gehan
    Azouz, Amany A.
    El-Nahass, EL-Shaymaa
    BIOORGANIC CHEMISTRY, 2018, 78 : 103 - 114